Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.
A number of drugs, including triptans, promote migraine chronification in susceptible individuals. In rats, a period of triptan administration over 7 days can produce "latent sensitization" (14 days after discontinuation of drug) demonstrated as enhanced sensitivity to presumed migraine triggers such as environmental stress and lowered threshold for electrically induced cortical spreading depression (CSD). Here we have used fMRI to evaluate the early changes in brain networks at day 7 of sumatriptan administration that may induce latent sensitization as well as the potential response to stress. After continuous infusion of sumatriptan, rats were scanned to measure changes in resting state networks and the response to bright light environmental stress. Rats receiving sumatriptan, but not saline infusion, showed significant differences in default mode, autonomic, basal ganglia, salience, and sensorimotor networks. Bright light stress produced CSD-like responses in sumatriptan-treated but not control rats. Our data show the first brain-related changes in a rat model of medication overuse headache and suggest that this approach could be used to evaluate the multiple brain networks involved that may promote this condition.
P.A.I.N. Group, Boston Children's Hospital, Waltham, Massachusetts; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and lino.becerra@childrens.harvard.edu.
L
L
Becerra
P.A.I.N. Group, Boston Children's Hospital, Waltham, Massachusetts;
J
J
Bishop
P.A.I.N. Group, Boston Children's Hospital, Waltham, Massachusetts;
G
G
Barmettler
Department of Pharmacology, University of Arizona, Tucson, Arizona.
Y
Y
Xie
Department of Pharmacology, University of Arizona, Tucson, Arizona.
E
E
Navratilova
Department of Pharmacology, University of Arizona, Tucson, Arizona.
F
F
Porreca
P.A.I.N. Group, Boston Children's Hospital, Waltham, Massachusetts; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
D
D
Borsook
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects* / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects* / Q000502:physiology; D013181:Cortical Spreading Depression; D008027:Light / Q000009:adverse effects; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D058825:Serotonin 5-HT1 Receptor Agonists / Q000494:pharmacology*; D013315:Stress, Psychological / Q000209:etiology / Q000503:physiopathology*; D018170:Sumatriptan / Q000494:pharmacology*
D058825:Serotonin 5-HT1 Receptor Agonists; D018170:Sumatriptan
chronic dosing; cortical spreading depression; fMRI; pain; sumatriptan